Labori KJ, Bratlie SO, Andersson B, Angelsen JH, Biörserud C, Björnsson B, Bringeland EA, Elander N, Garresori H, Grønbech JE, Haux J, Hemmingsson O, Liljefors MG, Myklebust TÅ, Nymo LS, Peltola K, Pfeiffer P, Sallinen V, Sandström P, Sparrelid E, Stenvold H, Søreide K, Tingstedt B, Verbeke C, Öhlund Det al.(2024) Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial Lancet Gastroenterol Hepatol, 9(3), 205-217 DOI 10.1016/S2468-1253(23)00405-3, PubMed 38237621
Farnes I, Kleive D, Verbeke CS, Aabakken L, Issa-Epe A, Småstuen MC, Fosby BV, Dueland S, Line PD, Labori KJ(2023) Resection rates and intention-to-treat outcomes in borderline and locally advanced pancreatic cancer: real-world data from a population-based, prospective cohort study (NORPACT-2) BJS Open, 7(6) DOI 10.1093/bjsopen/zrad137, PubMed 38155512
Jenul A, Stokmo HL, Schrunner S, Hjortland GO, Revheim ME, Tomic O(2023) Novel ensemble feature selection techniques applied to high-grade gastroenteropancreatic neuroendocrine neoplasms for the prediction of survival Comput Methods Programs Biomed, 244, 107934 DOI 10.1016/j.cmpb.2023.107934, PubMed 38016391